The Gross Margin of Ningbo Menovo Pharmaceutical Co Ltd (603538.SS) is 32.69%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 32.69% |
| 2024-12-31 | 30.85% |
| 2023-12-31 | 28.29% |
| 2022-12-31 | 39.17% |
| 2021-12-31 | 37.32% |
| 2020-12-31 | 34.07% |
| 2019-12-31 | 37.34% |
| 2018-12-31 | 31.92% |
| 2017-12-31 | 34.07% |
| 2016-12-31 | 36.40% |